Found: 86
Select item for more details and to access through your institution.
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 23, doi. 10.1177/13524585231222131
- By:
- Publication type:
- Article
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 8, p. 945, doi. 10.1177/13524585231172145
- By:
- Publication type:
- Article
Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 277, doi. 10.1177/13524585221136259
- By:
- Publication type:
- Article
Progressive motor impairment from "critical" demyelinating lesions of the cervicomedullary junction.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 74, doi. 10.1177/13524585221114438
- By:
- Publication type:
- Article
Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 8, p. 1248, doi. 10.1177/13524585211048401
- By:
- Publication type:
- Article
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2052, doi. 10.1177/1352458521988926
- By:
- Publication type:
- Article
MOG-IgG1 and co-existence of neuronal autoantibodies.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 8, p. 1175, doi. 10.1177/1352458520951046
- By:
- Publication type:
- Article
Inflammatory activity following motor progression due to critical CNS demyelinating lesions.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1037, doi. 10.1177/1352458520948745
- By:
- Publication type:
- Article
Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 895, doi. 10.1177/1352458520940983
- By:
- Publication type:
- Article
Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 667, doi. 10.1177/1352458520929192
- By:
- Publication type:
- Article
Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 2, p. 303, doi. 10.1177/1352458520907900
- By:
- Publication type:
- Article
Demographics and clinical characteristics of episodic hypothermia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 5, p. 709, doi. 10.1177/1352458518767045
- By:
- Publication type:
- Article
Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 11, p. 1445, doi. 10.1177/1352458518781979
- By:
- Publication type:
- Article
Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 331, doi. 10.1177/1352458517699791
- By:
- Publication type:
- Article
(RTH01) Safety of Satralizumab Based on Pooled Data from Phase 3 Studies in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD).
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 77
- By:
- Publication type:
- Article
COMMENTARY: Review: Magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosis.
- Published in:
- ACP Journal Club, 2006, v. 145, n. 2, p. 51, doi. 10.7326/acpjc-2006-145-2-051
- By:
- Publication type:
- Article
Cannabinoids did not reduce muscle spasticity in stablemultiple sclerosis: COMMENTARY.
- Published in:
- ACP Journal Club, 2004, v. 140, n. 3, p. 69, doi. 10.7326/acpjc-2004-140-3-069
- By:
- Publication type:
- Article
Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 9, p. 1190, doi. 10.1177/1352458517702556
- By:
- Publication type:
- Article
Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both important.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1404, doi. 10.1177/1352458514536254
- By:
- Publication type:
- Article
Christian Confavreux (1949 – 2013).
- Published in:
- 2013
- By:
- Publication type:
- Obituary
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 2, p. 188, doi. 10.1177/1352458512451510
- By:
- Publication type:
- Article
Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: No.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 9, p. 1211, doi. 10.1177/1352458512458043
- By:
- Publication type:
- Article
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 1, p. 5, doi. 10.1177/1352458511431077
- By:
- Publication type:
- Article
Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 5, p. 634, doi. 10.1177/1352458510394703
- By:
- Publication type:
- Article
Misdiagnosis of Multiple Sclerosis: Frequency, Causes, Effects, and Prevention.
- Published in:
- Current Neurology & Neuroscience Reports, 2013, v. 13, n. 12, p. 1, doi. 10.1007/s11910-013-0403-y
- By:
- Publication type:
- Article
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
What Is the Optimal Sequence of Rescue Treatments for Attacks of Neuromyelitis Optica Spectrum Disorder?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Specific pattern of gadolinium enhancement in spondylotic myelopathy.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 1, p. 54, doi. 10.1002/ana.24184
- By:
- Publication type:
- Article
Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, v. 8, n. 1, p. 1, doi. 10.1177/20552173211052159
- By:
- Publication type:
- Article
Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211052159
- By:
- Publication type:
- Article
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211052656
- By:
- Publication type:
- Article
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211048761
- By:
- Publication type:
- Article
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211052656
- By:
- Publication type:
- Article
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211048761
- By:
- Publication type:
- Article
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00501
- By:
- Publication type:
- Article
Evaluation of aquaporin-4 antibody assays.
- Published in:
- Clinical & Experimental Neuroimmunology, 2014, v. 5, n. 3, p. 290, doi. 10.1111/cen3.12107
- By:
- Publication type:
- Article
Neuromyelitis optica in western countries: Establishing diagnostic criteria and characterization of the spectrum.
- Published in:
- Neurology Asia, 2008, v. 13, p. 161
- By:
- Publication type:
- Article
Review: In relapsing–remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
- Published in:
- ACP Journal Club, 2014, v. 160, n. 6, p. 1
- By:
- Publication type:
- Article
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 4794, doi. 10.1007/s00415-024-12452-8
- By:
- Publication type:
- Article
Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 10, p. 4707, doi. 10.1007/s00415-023-11933-6
- By:
- Publication type:
- Article
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 3, p. 1286, doi. 10.1007/s00415-022-11488-y
- By:
- Publication type:
- Article
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 12, p. 2413, doi. 10.1002/acn3.51911
- By:
- Publication type:
- Article